Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
600

Summary

Conditions
Small Cell Lung Cancer
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 130 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03703297
Collaborators
Not Provided
Investigators
Study Director: Haiyi Jiang, M.D. AstraZeneca